Probable adverse effects of long term use of somatostatin analogues in patients with RA [5] (multiple letters)

Annals of the Rheumatic Diseases

Volumn 61, Issue 12, 2002, Pages 1117-

  Marcora, S ^a   Lemmey, A ^a   Madison, P ^b   Paran, D ^c   Elkayam, O ^c  

^a BANGOR UNIVERSITY   (United Kingdom)

^b YSBYTY GWYNEDD   (United Kingdom)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; GROWTH HORMONE; SOMATOSTATIN DERIVATIVE;

ANALGESIA; BODY COMPOSITION; BODY FAT; CARDIOTOXICITY; DISEASE ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG SAFETY; DWARFISM; GROWTH HORMONE DEFICIENCY; HORMONE SYNTHESIS; HUMAN; IMMUNOMODULATION; LETTER; MENTAL DISEASE; METABOLIC DISORDER; MUSCLE ATROPHY; MUSCLE WEAKNESS; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; WELLBEING;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMAN GROWTH HORMONE; HUMANS; LONG-TERM CARE; OCTREOTIDE; RANDOMIZED CONTROLLED TRIALS;

EID: 0036892872     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.61.12.1117     Document Type: Letter

References (0)